Navigation Links
How and why did 2011 Nobel winner Dan Shechtman persist despite rejection?
Date:10/14/2011

On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.

On October 5, 2011, Shechtman received the Nobel Prize in Chemistry.

What compelled Shechtman to stand by his research? What drove the men and women behind the most paradigm-shifting findings of the twentieth century? What motivates those few scientists who rise above their peers to achieve breakthrough discoveries?

In order to answer such questions, physical chemist and author Istvan Hargittai examines the careers of fifteen eminent scientists who achieved some of the most notable discoveries of the past century, assessing their motivation. In Drive and Curiosity, Dr. Hargittai provides an insider's perspective on the history of twentieth-century science. The author, who was personally acquainted with all but two of the scientists he profiles, includes:

  • Dan Shechtman, the aforementioned 2011 Nobel laureate and discoverer of quasicrystals
  • James D. Watson, the Nobel laureate and codiscoverer of the double helix structure of DNA
  • Linus Pauling, the Nobel laureate remembered most for his work on the structure of proteins
  • Edward Teller, a giant of the twentieth century who accomplished breakthroughs in our understanding of nuclear fusion
  • George Gamow, a pioneering scientist who devised the initially ridiculed and now accepted Big Bang

"Is there a recipe for research successes reaching the highest pinnacles? What are the common characteristics of discoveries that profoundly alter the world we live in?" asks Richard N. Zare, Stanford University, Wolf Prize laureate. "This fascinating book presents fifteen case studies that explore these questions in a manner both inviting and at once accessible."

In each case, Hargittai has uncovered a singular personality characteristic, motivational factor, or circumstance that, in addition to their extraordinary drive and curiosity, led these scientists to make outstanding contributions. For example, Gertrude B. Elion, who discovered drugs that saved millions of lives, was motivated to find new medications after the deaths of her grandfather and later her fianc. F. Sherwood Rowland, who stumbled upon the environmental harm caused by chlorofluorocarbons, eventually felt a moral imperative to become an environmental activist. Rosalyn Yalow, the codiscoverer of the radioimmunoassay, always felt she had to prove herself in the face of prejudice against her as a woman.

When it comes to "science, discovery and scientists," adds Nobel laureate Jean-Marie Lehn, it matters to be "the right person, at the right time, in the right place. This book provides a thoughtful and vivid analysis of how scientific progress happens through some selected case studies. It should be of value to [anyone] who wishes to get insight into the various processes underlying the quest for knowledge."


'/>"/>
Contact: Meghan Quinn
mquinn@prometheusbooks.com
800-853-7545
Prometheus Books
Source:Eurekalert  

Related medicine news :

1. Nobel Prize in Physiology or Medicine 2011: Jules Hoffmann
2. UT Southwestern scientist shares 2011 Nobel Prize in Physiology or Medicine
3. Lifespan researcher wins Ig Nobel Prize
4. Nobel laureates Brown, Goldstein to give inaugural Stadtman award lecture
5. 2010 Chemistry Nobel laureate Ei-ichi Negishi leads C&EN webinar
6. NIDA Avant-Garde-Medications Development Award winners announced
7. HJF names 2011-12 fellowship award winners
8. Joint winners announced in Research4life global case study competition
9. BUS Jeffrey H. Samet, M.D., selected as a 2011 NIDA International Program Awards of Excellence winner
10. Reed Elsevier Environmental Challenge winners announced
11. Cephalalgia Award Lecture winner announced
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
How and why did 2011 Nobel winner Dan Shechtman persist despite rejection?
(Date:3/22/2017)... NJ (PRWEB) , ... March 22, 2017 , ... ... Group, the nation’s leading digital and print media enterprise focused on cancer patients, ... video content, has released a special 12-part educational video series, “No Ifs, Ands, ...
(Date:3/22/2017)... ... March 22, 2017 , ... An intensive search of the ... HIV, reports Leslie Norins, MD, PhD. He says investigating this possibility, is ... Zika virus and in new infections with HIV. , His findings appear ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... Last year, ... to a US Department of Agriculture report. While excess dairy can be caused ... a role. Lactose sensitivity is the inability to properly digest lactose, a sugar found ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Vanderbeck Agency, a Long Island ... County region, is embarking on a combined charity effort with the Great Neck Breast ... last 25 years, the Great Neck Breast Cancer Coalition has worked to support breast ...
(Date:3/22/2017)... ... March 22, 2017 , ... The ... related services to families and business owners in the greater Nassau County area, ... & Lymphoma Society. , Every 3 minutes, someone in America is diagnosed with ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... March 22, 2017  CANTEL MEDICAL CORP. (NYSE: ... President and CEO, will be presenting at the 16 th ... Grand Central Hotel in New York . ... at 3:00 p.m. ET. In addition, management will be available ... A live audio webcast will be available via the investor ...
(Date:3/22/2017)... 2017  Ablation is the minimally invasive therapeutic ... of purposes, from cancerous or diseased tissue removal, ... in atrial fibrillation and others. The growing adoption ... to innovate and improvise existing ablation technologies for ... global market is expected to grow at high ...
(Date:3/22/2017)... LINCOLN, Mass. , March 22, 2017 /PRNewswire/ ... applying mechanistic modeling to drug research and development, ... QSP Day 2017.  QSP Day 2017 is a ... with the quantitative systems pharmacology (QSP) community. The ... mathematical modeling is de-risking and accelerating drug research ...
Breaking Medicine Technology: